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The function of G protein-coupled receptors
(GPCRs) can be modulated by a number of endoge-
nous allosteric molecules. In this study, we used
molecular dynamics, radioligand binding, and ther-
mostability experiments to elucidate the role of the
recently discovered sodium ion binding site in the
allosteric modulation of the human A2A adenosine
receptor, conserved among class A GPCRs. While
the binding of antagonists and sodium ions to the
receptor was noncompetitive in nature, the binding
of agonists and sodium ions appears to require
mutually exclusive conformational states of the
receptor. Amiloride analogs can also bind to the
sodium binding pocket, showing distinct patterns
of agonist and antagonist modulation. These findings
suggest that physiological concentrations of sodium
ions affect functionally relevant conformational
states of GPCRs and can help to design novel
synthetic allosteric modulators or bitopic ligands
exploiting the sodium ion binding pocket.
INTRODUCTION
Cellular responses to a wide variety of extracellular signals are
mediated by the superfamily of seven-transmembrane helical
receptors coupled to intracellular G proteins (G protein-coupled
receptors [GPCRs]). It is now well recognized that many GPCRs
function as ‘‘allosteric machines,’’ with the orthosteric binding
pocket representing just one of themany sites for possible signal
modulation and pharmacological intervention. Thus, molecules
targeting other (allosteric) sites can modulate binding of native
orthosteric ligands and shift the delicate equilibrium between
active and inactive states of GPCRs (Christopoulos, 2002).Structure 21, 2175–21Potential therapeutic advantages include a gain in target selec-
tivity, the ‘‘ceiling effect,’’ and preservation of the spatiotemporal
profile of intercellular signaling (Conn et al., 2009; Gao and
Jacobson, 2006; Go¨blyo¨s and Ijzerman, 2011; Jacobson et al.,
2011). Some endogenous chemical entities, such as ions or
lipids, have also been demonstrated to act as allosteric modula-
tors of GPCRs (Christopoulos, 2002; Gao and Ijzerman, 2000;
Neve et al., 2001), but the structural basis and functional impor-
tance of these interactions are not well understood.
Recent advances in protein engineering and membrane pro-
tein crystallography (Cherezov, 2011; Rosenbaum et al., 2007;
Tate and Schertler, 2009) have led to the elucidation of a growing
number of experimental GPCR structures (Katritch et al., 2013),
contributing to the alluring perspective of structure-based drug
design (Congreve et al., 2011) and the deciphering of molecular
mechanisms underlying conformational equilibrium (Dror et al.,
2009). Several receptors, including one of the best-character-
ized GPCRs, the A2A adenosine receptor (A2AAR), have been
crystallized in inactive (Congreve et al., 2012; Dore´ et al., 2011;
Hino et al., 2012; Jaakola et al., 2008) and active-like (Lebon
et al., 2011; Xu et al., 2011) conformations. The conformational
changes associated with A2AAR activation mirrored similar
structural changes observed in other receptors, namely the
b2-adrenergic receptor (b2AR) (Rasmussen et al., 2011) and
rhodopsin (Park et al., 2008). Recently, the 1.8 A˚ resolution struc-
ture of inactive A2AAR in complex with ZM241385 (Liu et al.,
2012) revealed the presence of a sodium ion bound to the core
of the transmembrane (TM) bundle, coordinated by Asp2.50 and
other side chains highly conserved in class A GPCRs (Mirzade-
gan et al., 2003) and by a cluster of structural water molecules
(Angel et al., 2009; Pardo et al., 2007). The allosteric effect of
sodium ions has been described previously in A2A (Gao and Ijzer-
man, 2000) and A1 adenosine receptors (Barbhaiya et al., 1996),
aswell as in GPCRs from other subfamilies such as dopamine D2
(Neve et al., 2001; Selent et al., 2010), opioid (Pert et al., 1973;
Snyder and Pasternak, 2003), or a-adrenergic receptors (Horst-
man et al., 1990; Tsai and Lefkowitz, 1978), among others.
Similarly, the positively charged, synthetic small molecule85, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2175
Table 1. Setup of the Different MD Simulations Reported in this
Work
Receptor
Conformation Ligand
Allosteric
Modulator
Replicas,
Length (ns)
MDS1 inactive ZM241385 Na+ 3 3 100
MDS1ba inactive ZM241385 Na+ 3 3 100
MDS2 inactive — Na+ 3 3 100
MDS3 inactive ZM241385 — 3 3 100
MDS4 inactive — — 3 3 100
MDS5 active UK432097 Na+ 3 3 40
MDS6 active NECA Na+ 3 3 40
MDS7 active — Na+ 3 3 40
MDS8 inactive ZM241385 amiloride 3 3 100
MDS9 inactive caffeine amiloride 3 3 40
MDS10 inactive caffeine — 3 3 40
MDS11 inactive ZM241385 HMA 3 3 100
MDS12 inactive caffeine HMA 3 3 40
aMDS1b corresponds to the same system as MDS1, but considering the
physiological saline concentration of 150 mM.
Structure
Allosteric Effects of Sodium Ions on A2A Receptoramiloride and its analogs have also been found as allosteric
modulators of agonist and antagonist binding in a number of
receptors, including A2AAR, and were shown to compete with
sodium ions for the same binding site (Gao and Ijzerman,
2000). Moreover, mutation of Asp2.50 to either asparagine or
alanine has been shown to reduce or abrogate the allosteric
effects of sodium ions or amiloride in many GPCRs (Gao et al.,
2003a; Neve et al., 2001; Nie and Lewis, 2001; Proulx et al.,
2008). While the 1.8 A˚ structure of A2AAR provides a static pic-
ture of sodium interactions with the receptor, the dynamic nature
of the sodium ion/water cluster, its effect on binding of orthos-
teric agonists and antagonists, and its functional role are poorly
understood. Molecular dynamics (MD) studies, supported by
biochemical and biophysical characterization of the complexes
here, provide a molecular framework for the allosteric effects
of sodium and amilorides, which can ultimately aid in the dis-
covery of new compounds targeting this site (Go¨blyo¨s and
Ijzerman, 2011).
RESULTS
Molecular Dynamics Studies
A series of MD simulations were designed to evaluate the func-
tional role of the sodium ion in the A2AAR, as summarized in
Table 1. Three MD replicates of 40–100 ns length each were
run for each setup, in order to increase the statistics of the
sampling, with a total simulation time exceeding 2.8 ms. The
effect of the sodium ion on the conformational equilibrium of
the receptor was examined considering both the inactive and
active-like conformation of the A2AAR (simulations MDS1–
MDS7). The influence of the orthosteric ligands in this process
was examined by comparing the MD simulations with and
without the antagonist ZM241385 (MDS1 and MDS2) or the
agonists UK432097 and NECA (MDS5 through MDS7). In
addition, the allosteric effect of amiloride and its derivative
HMA [5-(N,N-hexamethylene)amiloride] in the antagonist-bound2176 Structure 21, 2175–2185, December 3, 2013 ª2013 Elsevier Ltdconformation was examined in MDS8 through MDS12, with
two distinct chemotypes of antagonists (i.e., ZM241385 and
caffeine).
The Sodium Binding Site in the A2AAR Inactive
Conformation
In the high-resolution crystal structure of inactive A2AAR (Liu
et al., 2012), the sodium ion is directly coordinated by
Asp522.50 and Ser913.39 (first-shell residues) and three struc-
tured water molecules (Figure 1A). Water molecules also bridge
interactions with residues in the second (Trp2466.48 and
Asn2807.45) and third shells (Thr883.36 and Ser2817.46). Overall,
the sodium ion/water binding pocket is formed by 15 out of the
34 amino acids that are conserved in themajority of nonolfactory
class A GPCRs (Mirzadegan et al., 2003) and their conformation
is similar in most GPCRs crystallized in the inactive state (Figures
1B–1D and Figure S1 available online).
Analysis of the sodium ion’s mobility and its coordination state
reveals a high level of stability for the ion when bound to the re-
ceptor’s inactive conformation. The dominant charge-charge
interaction with Asp522.50 is clearly maintained along the simula-
tion runs in the different MD trajectories, while the side-chain
oxygen atoms of Ser913.39 and Asn2807.45 alternate direct inter-
actions with the ion (Figure 2A). More precisely, the ion fluctuates
between a coordination state as seen in the crystal structure,
which we will refer to as position c1, and a second state, which
we will refer to as position c2. This fluctuation involves an ex-
change between the sodium ion and the water molecule W52,
initially linked to the OD1 of Asn2807.45, as shown in Figure 2A
by the overlay of the electron density of the crystal structure
with the volumetric density map calculated from the MD simula-
tions. In position c2, the ion is still coordinated by Asp522.50
(OD1), while it is the OD1 of Asn2807.45 (occasionally replaced
byanewwatermolecule) that participates in the first coordination
shell, which is completed with three other water molecules. The
radial distribution function indicates the average sodium-oxygen
distance is 2.4 A˚, with the first coordination shell predominantly
formedby four or five oxygenatoms (seeFigureS2), in agreement
with the geometric analysis of sodium ion binding sites found in
the Protein Data Bank (PDB) (Harding, 2006). The consistent
observation of these twodominant coordinationmodes suggests
a possibility of fast exchange between the sodium ion and the
water molecule, supported by the significantly shorter distance
(2.2 A˚) observed in the crystal structure for the Na+-O(W52)
pair. Interestingly, this fast exchange occurs regardless of the
presence of the antagonist ZM241385 in the orthosteric binding
site (Table S1). In the setup MDS1b, we evaluated the effects of
a physiological saline concentration in the simulations and
observed no difference in results (Figure S3 and Table S1). More-
over, none of the sodium ions from the extracellular solvent envi-
ronment could cross the narrowchannel into the allosteric pocket
during 100 ns simulations, suggesting that exchange of sodium
ions in A2AAR may occur on a longer timescale.
To investigate a possible effect of the sodium ion on the stabil-
ity of the inactive conformation of the receptor, the MD simula-
tions described above (MDS1 and MDS2) were compared with
the corresponding simulations of the inactive A2AAR in the
absence of the ion (MDS3 andMDS4). Themost pronounced dif-
ference in local conformational dynamics was located in theAll rights reserved
Figure 1. Structure and Conservation of the
Central Sodium Ion Binding Allosteric
Pocket in Class A GPCRs
(A) The sodium ion distorted octahedral coordi-
nation as in the A2AAR crystal structure. The first
shell is occupied by two conserved polar residues
(green) and three water molecules, which contact
with a second shell of residues (cyan), or with a
second layer of water molecules connecting with
the third shell of residues (magenta).
(B) Sequence conservation of the 15 residues
lining the binding pocket among inactive GPCR
crystal structures.
(C) Structure of the A2AAR complex with
ZM241385, showing residues with higher than
50% conservation in all class A receptors as sticks
with green carbons.
(D) A close-up of the central allosteric pocket
(transparent blue surface), showing the side
chains located within 5 A˚ from the ten waters
of the sodium ion/water cluster (green sticks:
A2AAR; gray thin lines: the corresponding side
chains of the overlaid GPCR crystal structures
listed in B).
See also Figure S1.
Structure
Allosteric Effects of Sodium Ions on A2A Receptorregion of the sodium ion: the highly conserved residue Trp2466.48
in the second sphere of solvation experienced a rotameric tran-
sition from the initial g+ rotamer to the trans (t) conformation,
observed in two out of three independent simulations of the
apo receptor without sodium ion (MDS4; see Figure 3). This rota-
meric change appears connected to a rotation of residue
Asn2807.45 from the initial g rotamer to either trans or g+ (Fig-
ures 3A and 3C). In contrast, rotamer changes in Tpr2466.48
and, to a lesser extent, Asn2807.45 were not observed when
the sodium ion was bound to the allosteric site (MDS2), suggest-
ing that the sodium ion contributes to a stabilization of these two
residues (Figures 3A and 3B). Similarly, the furyl moiety of the
antagonist ZM241385 stabilized the g+ rotamer of Trp2466.48
through van der Waals interactions (simulations MDS1 and
MDS3). Consequently, no movements in this microenvironment
occurred with ZM241385 bound, regardless of the presence of
the sodium ion.
The Sodium Ion Binding Site in the A2AAR Active-like
Conformation
Analysis of the agonist-bound structures of A2AAR (Lebon et al.,
2011; Xu et al., 2011) indicates that the activation-relatedStructure 21, 2175–2185, December 3, 2013 ªchanges in helix VII partially collapse the
sodium ion pocket, making it incompat-
ible with ion binding (Liu et al., 2012). In
order to further evaluate this effect, the
sodium ion/water cluster was simulated
in the context of the active-like conforma-
tion of A2AAR with agonists UK432097
(MDS5) or NECA (MDS6) or without any
agonist (MDS7; see Table 1). The simula-
tions show that in the active-like state the
receptor cannot bind the sodium ion, as
evidenced by two alternative events thatoccur in the early stages of production runs. In the first event
(observed in one out of three replicas inMDS5, in two out of three
replicas in MDS6, and in all three replicas in MDS7), the ion
escaped from the proposed binding site. In the alternative event,
observed in the remaining simulations, the ion remained in the
allosteric binding site but a conformational change of helix VII
occurred, resembling the inactive-like conformation of helix VII
observed in all antagonist-bound A2AAR structures. In particular,
the region between His2787.43 and Asn2847.49 undergoes an
outward movement driving helix VII apart from helix III and ex-
panding the pocket cavity (Figure 4). In the MDS5 and MDS6
simulations, this rearrangement was also accompanied by a
loss of contact between His2787.43 and the O20 of the ribose
moiety of the agonist, suggesting that sodium ion binding desta-
bilizes activation-related movements and agonist binding. Note
that all conformational events described here occurred within
the first 5–10 ns of the simulation, justifying that a total simulation
time of 40 ns was sufficient to properly sample the sodium bind-
ing site in the active-like system. These findings indicate that the
binding of sodium ions and agonists each requires a different
conformational state of the receptor and, therefore, is mutually
exclusive.2013 Elsevier Ltd All rights reserved 2177
Figure 2. The Two Coordination States of the Sodium Ion as
Observed in MD Simulations
(A) Volumetric density map (isosurface contoured at 0.3 A˚3 value, blue) cor-
responding to the sodium ion occupancy as calculated from simulationsMDS1
(see Table 1). The starting crystal structure is displayed, together with the
electron density (contoured at 1 s level, black).
(B) The time evolution of the distances between the sodium ion and Asp2.50
(blue), Ser3.39 (red), and Asn7.45 (green), shown for the three independent
replicates (R1–R3) of MDS1. The corresponding distances are denoted as
dashed lines in (A) with the same color code and are the source of the data in
Table S1. The root-mean-square deviation (rmsd) of the ion with respect to its
crystallographic position is indicated with a black line, while the horizontal bar
at 1.8 A˚ (the resolution of the parent crystal structure) denotes the limit for the
crystallographic coordination state (position c1).
See also Table S1 and Figure S2.
Figure 3. Rotameric Transitions of Trp6.48 and Asn7.45 in the apo Sim-
ulations of the Inactive A2AAR
(A) Populations of the initial conformational states in the simulations with
(MDS2) and without (MDS4) the sodium ion, and the number of waters in the
ion binding site (each data is an average of the three MD replicas). Note that
Trp6.48 only finds the trans conformation when not in the initial g+ conforma-
tion, while Asn7.45 is more flexible and can be found in trans, g+, or the initial g
conformations.
(B and C) Representative snapshot (magenta) of the conformation of these two
residues in MDS2 (B) and MDS4 (C), with the reference crystal structure
overlaid in light gray.
Structure
Allosteric Effects of Sodium Ions on A2A ReceptorAmiloride and HMA as A2AAR Allosteric Modulators
Amiloride and its derivatives are known to be nonspecific GPCR
modulators (Garritsen et al., 1991). A binding mode of amiloride
and its bulkier analog HMA to the A2AARwas determined by flex-2178 Structure 21, 2175–2185, December 3, 2013 ª2013 Elsevier Ltdible side-chain docking where the charged guanidinium group of
amiloride interacted with Asp522.50 (Liu et al., 2012). An addi-
tional hydrogen bond was also predicted between amiloride
and the Trp2466.48 side chain (see Figure 5A), which is shifted
1.5 A˚ toward the orthosteric pocket as a result of induced fit.
This tight binding of amilorides is clearly not compatible withAll rights reserved
Figure 4. The Movement of Helix VII in Order to Accommodate the
Sodium Ion
(A) Starting (grey) and ending (rainbow, with helix VII colored orange) confor-
mations of the agonist-bound A2AAR in the presence of sodium ion (MDS5),
with the inactive crystal structure denoted in anthracite.
(B) The distance between helices III and VII (x axis, Ca of residues Ile3.40 and
Asn7.45 as indicated by a dashed line in the 3D structure) is plotted against the
backbone rmsd of the motif His7.43-Asn7.49 (y axis), using as a reference the
inactive conformation of A2AAR. Each dot is a snapshot extracted every 0.5 ns,
with the time evolution depicted by the shading code (light gray to black).
Active and inactive conformations are indicated with an asterisk and a triangle,
respectively.
Structure
Allosteric Effects of Sodium Ions on A2A Receptorthe collapsed allosteric pocket observed in the active-like
conformation of the A2AAR, in an even more pronounced way
than in the case of sodium ions. Therefore, we explored this
docking hypothesis with a series of MD simulations of the inac-
tive A2AAR in the presence of different orthosteric antagonists,Structure 21, 2175–21i.e., the ternary complexes A2AAR-ZM241385-amiloride (MDS8)
and A2AAR-caffeine-amiloride (MDS9). The effect of amiloride
on the binding of antagonists turned out to be complex and
varied between the different antagonist chemotypes tested. Fig-
ure 5D shows a comparison of the root-mean-square fluctuation
(rmsf) of compound ZM241385 with no allosteric modulator pre-
sent (MDS3) and with either sodium ion (MDS1), amiloride
(MDS8), or HMA (MDS11) present in the proposed allosteric
site. A significant increase in the mobility of ZM241385 (p <
0.05) was observed in the presence of both amilorides. This
effect is likely due to the influence of the side chain of
Trp2466.48, which is the only residue that interacts with
ZM241385 and amilorides simultaneously (in particular with the
N-hexamethylene substituent of HMA; see Figure 5C), leading
to the hypothesis that this highly conserved residue acts as an
important link between the two sites. Consequently, binding of
antagonists that do not directly interact with Trp2466.48 (for
example, caffeine; Dore´ et al., 2011) should be less affected by
the presence of amiloride in the allosteric site (Figure 5B). Indeed,
we found no statistically significant difference for the mobility of
caffeine as a function of the presence of amilorides (Figure 5D).
Due to the high mobility of caffeine, which is small in size, has
few receptor contacts, and displays low affinity, the simulation
time in this particular system was limited to a 40 ns timescale.
Biochemical Studies
Radioligand binding experiments were performed to examine
the effects of sodium ions and amiloride derivatives on antag-
onist, [3H]ZM241385, and agonist, [3H]NECA, binding to the
A2AAR. In order to experimentally assess the dependence of
ligand binding on the presence of a sodium ion in the allosteric
site, we performed equilibrium displacement studies with
increasing concentrations of NaCl (Figure 6A). These experi-
ments show a full displacement of [3H]NECA by sodium ions,
with a half maximal inhibitory concentration (IC50) value of 49 ±
7mM (Table S2; Figure 6A). In contrast, there is an enhancement
of antagonist [3H]ZM241385 binding, especially at higher sodium
ion concentrations. All these results correlate with the MD con-
clusions that the sodium ion selectively stabilizes the antago-
nist-bound receptor state.
Saturation binding experiments performedwith [3H]NECA also
show that the presence of NaCl significantly reduces [3H]NECA
binding to the A2AAR (Table 2; Figure S3). Interestingly, this
reduction in agonist binding was due to an increase of the KD
value while the radioligand’s Bmax value remained at a control
level, within experimental error. This profile of pharmacological
parameters usually implies a competitive interaction between
the two ligands. However, in this case the binding sites of the
two ligands are not overlapping, so the observed ‘‘mutually
exclusive binding’’ suggests that the sodium-ion-bound con-
formation of A2AAR is not compatible with agonist binding and
vice-versa. In contrast, no significant effect of sodium ions was
observed on the binding of the antagonist radioligand
[3H]ZM241385 to the A2AAR (Table 2).
We also characterized the influence of amiloride and HMA on
radioligand binding to the A2AAR. The two compounds inhibited
the binding of both agonist and antagonist radioligands in
displacement assays, albeit with different potencies (Figures
6B and 6C; Table S2). HMA proved to be more active than85, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2179
Figure 5. Impact of Amiloride and HMA on
the Binding of Antagonists
(A) Amiloride docking (magenta carbons) induces
a shifted position of Trp2466.48 side chain, re-
vealing potential steric clasheswith the orthosteric
ligand ZM241385 (yellow carbons, superimposed
from the crystal structure with PDB code 4EIY).
(B) The same conformation of the amiloride-bound
A2AAR, with the caffeine pose (green carbons)
superimposed from the crystal structure of A2AAR/
caffeine complex (PDB code 3RFM).
(C) Flexible docking of HMA (magenta carbons) is
predicted to further shift Trp2466.48 and interfere
with ZM241385 binding.
(D) Mobility of the antagonists in the presence or
absence of amiloride, HMA, and sodium ion in the
allosteric pocket, calculated as the rmsf from the
MD simulations (dark shaded bars for ZM241385;
light shaded bars for caffeine). The error bars
indicate the SD estimated from three MD replicas
(n = 3); ami, amiloride; ZM, ZM241385. Signifi-
cantly different from the control simulation (i.e.,
absence of any allosteric ligand) in a Student’s
t test with *p < 0.05.
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Allosteric Effects of Sodium Ions on A2A Receptoramiloride in both cases and displayed the highest potency
(2.4 mM) with the agonist [3H]NECA as the radiolabel. Radioli-
gand saturation experiments were performed in the presence
of the amiloride analogs, revealing distinct differences between
the two radioligands (Table 2; Figure S3). The interaction
between amiloride and [3H]ZM241385 was noncompetitive in
nature, as the radioligand’s Bmax value was significantly reduced
with little effect on the KD value, whereas unlabeled ZM241385,
serving as a control orthosteric ligand, showed all traits of a
competitive ligand. In this experimental setup, HMA behaved
somewhat in between ZM241385 and amiloride, showing a small
but significant shift in KD and a nonsignificant change in Bmax
value. Similar experiments with the radiolabeled agonist
[3H]NECA produced a very different outcome. While unlabeled
ZM241385 appeared competitive with [3H]NECA, as expected
for two orthosterically binding compounds, the same was true
for the interaction between the amilorides and [3H]NECA. Hardly
any effect was observed on NECA’s Bmax value, whereas all KD
values were significantly increased, which we attribute to the
mechanism of ‘‘mutually exclusive binding’’ discussed above
for the case of agonist and sodium ion binding.2180 Structure 21, 2175–2185, December 3, 2013 ª2013 Elsevier Ltd All rights reservedBiophysical Studies
The effects of sodium ions, orthosteric
ligands, and amiloride analogs on A2AAR
stability were analyzed with a series
of thermal stability assays (Alexandrov
et al., 2008). Increasing sodium ion con-
centrations induced a significant increase
in the thermostability of the unliganded
A2AAR-BRIL complex, as shown in Fig-
ure 7A. A two-phase response was
observed, with a modest increase in ther-
mostability from 52C to 57C at sodium
ion concentrations below the physiolog-ical concentration of 150 mM and a further more substantial
increase to 65C upon addition of higher concentrations up to
500 mM NaCl.
In order to evaluate the effects of allosteric modulators on
various receptor-ligand complexes, we measured the thermal
stability of the A2AAR-BRIL construct in the presence or absence
of sodium ions and/or amiloride and their combinations with the
orthosteric ligands caffeine (antagonist), ZM241385 (antagonist),
or UK432097 (full agonist) (Figure 7B). Sodium ions and amiloride
each increased A2AAR thermostability by 5
C–6C, but their
effect when combined was nonadditive, corroborating the sug-
gested competition of these two charged molecules for the
same binding site. In contrast, the addition of caffeine in the
presence of saturating concentrations of amiloride or sodium
ions caused a further 6C increase in the thermostability of the
complex, suggesting an additive stabilizing effect of the orthos-
teric caffeine and allosteric ligands. Also, while we observed an
additive effect of sodium ions and ZM241385, amiloride did not
contribute to the stability of A2AAR in saturating concentrations
of ZM241385, in agreement with unfavorable indirect interac-
tions between amiloride and ZM241385. Finally, neither sodium
Figure 6. Equilibrium Displacement of [3H]ZM241385 and [3H]NECA
by Allosteric Modulators
NaCl (A), amiloride (B), and HMA (C). Representative graphs from one exper-
iment performed in duplicate on human A2AARs transiently expressed in
HEK293T cell membranes. Associated IC50 values are listed in Table S2.
Table 2. Saturation Binding of [3H]ZM241385 and NECA Spiked
with 25% [3H]NECA to Human A2AARs Transiently Expressed in
HEK293T Cell Membranes in the Absence and Presence of
ZM241385, NaCl, Amiloride, and HMA
[3H]ZM241385 [3H]NECA
KD (nM) Bmax
a (%) KD (nM) Bmax
a (%)
Control 1.3 ± 0.4 100 ± 10 84 ± 11 100 ± 2
+10 nM ZM 8.3 ± 2.2b 85 ± 7 123 ± 9c 95 ± 3
+30 mM NaCl 1.2 ± 0.3 120 ± 11 213 ± 10d 106 ± 4
+100 mM NaCl 0.8 ± 0.1 87 ± 3 471 ± 53d 114 ± 9
+30 mM amiloride 1.9 ± 0.8 61 ± 4c 290 ± 52b 119 ± 13
+3 or 4 mM HMAe 4.1 ± 0.9c 78 ± 9 246 ± 2d 110 ± 1c
Values are means ± SEM of two to five separate assays performed in
duplicate. See associated experiments in Figure S3.
a% of Bmax of control ( = 100%).
bSignificantly different from control in a Student’s t test with p < 0.01.
cSignificantly different from control in a Student’s t test with p < 0.05.
dSignificantly different from control in a student t test with p < 0.001.
e3 mM HMA for [3H]ZM241385 and 4 mM HMA for [3H]NECA.
Structure
Allosteric Effects of Sodium Ions on A2A Receptorions nor amiloride had a stabilizing effect on the A2AAR saturated
with UK432097, likely because this agonist precluded binding of
these allosteric modulators.
DISCUSSION
The 1.8 A˚ resolution structure of A2AAR in complex with the
antagonist ZM241385 (Liu et al., 2012) revealed a highly
conserved sodium ion binding site and provided an excellent
opportunity to examine the molecular mechanism of the allo-
steric modulation of sodium ions in this receptor. Our MD simu-
lations suggest that the electron density assigned to the water
molecule closest to sodium ion in the crystal structure (W52)
could correspond to a second resonance position of the ion,Structure 21, 2175–21which would involve direct interaction with another conserved
residue, Asn2807.45. Although we could not find a clear evidence
of such dynamic rearrangements in the A2AAR crystal structure,
thismay reflect the ‘‘frozen’’ state of the sodium ion/water cluster
at the low temperatures (100 K) used in cryocrystallography.
While further crystallographic studies at room temperature may
help to validate such subtle effects experimentally (Fraser
et al., 2011), the thermal fluctuations explored by the MD simu-
lations under physiological conditions are particularly suited to
explore this phenomenon (Ulmschneider et al., 2013). The poten-
tial dynamic nature of the sodium ion and water network in the
allosteric pocket could partially explain why the ion was not
observed previously in lower-resolution GPCR structures. A
closer look at this region in two recently published, antagonist-
bound GPCR structures, i.e., carvedilol-b1-adrenergic receptor
(Warne et al., 2012) and bFNA-m opioid receptor (Manglik et al.,
2012), reveals that they are indeed compatible with the presence
of a sodium ion (Figure S1). Most recently, a similar configuration
of the sodium ion/water network was also identified in other
ligand complexes of the b1-adrenergic receptor (Christopher
et al., 2013).
The communication between the highly conserved class A
GPCR residues Asp2.50, Trp6.48, and, to a lesser extent, Asn7.45
had been suggested to occur through a cluster of water mole-
cules (Pardo et al., 2007). The current MD results strongly
support the preference of the sodium ion for the inactive confor-
mation of this microenvironment, at least in the A2AAR, suggest-
ing that it contributes to its stabilization. The increased dynamic
flexibility of Trp2466.48 and Asn2807.45 in the absence of the
sodium ion is consistent with previous MD simulations of the
A2AAR (Rodrı´guez et al., 2011) and agrees well with similar MD
simulations in the dopamine D2 receptor with explicit consider-
ation of a sodium ion (Selent et al., 2010). The conformational
flexibility of Trp6.48 has been associated with the initial steps of
the activation mechanism of GPCRs (Schwartz et al., 2006; Shi
and Javitch, 2002), probably by facilitating the higher-order
conformational changes observed in helix VI between inactive85, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2181
Figure 7. Effect of Allosteric Binders on A2AAR Thermostability
Measured by CPM Assay
(A) Effect of NaCl titration on A2AAR thermostability; mean ± SEM shown for
measurements performed in triplicate.
(B) Effect of NaCl (150 mM), amiloride (100 mM), caffeine (500 mM),
ZM241385 (50 mM), UK432097 (50 mM), and combinations thereof on A2AAR
thermostability.
Structure
Allosteric Effects of Sodium Ions on A2A Receptorand active states. Conversely, the presence of the sodium ion
and coordinating water molecules in this pocket hampers an
activation-related inward movement of helix VII toward helix III
(Lebon et al., 2011; Xu et al., 2011), as indicated by MD simula-
tions. Instead, we observed an ‘‘inactivation’’ movement of helix
VII in the agonist-bound conformation that led to the loss of key
agonist-receptor interactions, suggesting that the simultaneous
binding of the allosteric ion and the orthosteric agonist to the
same receptormolecule is unlikely. Such a structural mechanism
explains the negative allosteric effect of sodium ions on agonist
binding to the A2AAR observed here (Figure 6A; Table 2) and in
earlier studies (Gao and Ijzerman, 2000; Liu et al., 2012).
In radioligand binding experiments performed with both
agonist and antagonist radioligands, sodium ions differentially
affect radioligand binding to the A2AAR, providing further insights
into its allosteric effect: they induced an increase in
[3H]ZM241385 binding but abrogated [3H]NECA binding in a
concentration-dependent manner with an IC50 value of approxi-
mately 50 mM. This potency is in the same range of sodium ion2182 Structure 21, 2175–2185, December 3, 2013 ª2013 Elsevier Ltdconcentrations that cause an increase in receptor thermostability
(Figure 7), indicating that sodium ion binding could mediate both
effects.Moreover, this IC50 corresponds to about one-third of the
extracellular physiological concentration of sodium. This
suggests that about 75% of the A2AARs are in a sodium-ion-
occupied state, provided that there is unrestricted access to
the sodium binding site from the outside of the cell as recently
proposed for the dopamine D2 receptor (Selent et al., 2010).
Thus, it is likely that sodium is significantly involved inmodulating
the physiological state of the A2AAR and possibly other class A
GPCRs. Interestingly, the saturation binding experiments (Table
2) demonstrate that the presence of sodium ions (30 and
100mM) reduces [3H]NECAaffinity (KD) rather than itsBmax value,
while no affinity reduction was observed for [3H]ZM241385. This
fact, together with the observed increase of [3H]ZM241385 bind-
ing at high sodium ion concentrations (Figure 6A), is in good
agreement with an earlier study (Gao et al., 2000) where the slight
affinity increase of this radioligand at even higher [1 M] sodium
concentrations was due to a decrease in its dissociation rate
(Gao and Ijzerman, 2000). The structural information and the
computational results provided in this study suggest that binding
of agonists and sodium ions can be considered as ‘‘mutually
exclusive’’ (Neubig et al., 2003). This mechanism is further sup-
ported by thermal stability assays showing that antagonists
ZM241385 and caffeine display additive stabilizing effects with
sodium ions, whereas the agonist UK432097 stabilizes the re-
ceptor but shows no additive effect when any allosteric ligand
is added.
Similar to sodium ions, the diuretic drug amiloride is an allo-
steric modulator of several GPCRs, including such diverse sub-
families as adenosine, aminergic, and gonadotropin-releasing
hormone receptors (Gao and Ijzerman, 2000; Gao et al.,
2003b; Heitman et al., 2008; Hoare et al., 2000; Howard et al.,
1987; Pauwels, 1997). The present study in the human A2AAR
shows that both amiloride and its derivative HMA negatively
modulate agonist binding (Table 2), with HMA being more potent
than amiloride in radioligand displacement studies (Figure 6) as
previously suggested with kinetic studies in the rat A2AAR (Gao
and Ijzerman, 2000). The saturation studies with [3H]ZM241385
as the radioligand (Table 2) also point to a noncompetitive
interaction between amiloride and the antagonist binding site.
Moreover, the additive increase in A2AAR thermostability in the
presence of both amiloride and the orthosteric antagonist
caffeine (Figure 7) suggests that both allosteric and orthosteric
ligands can bind simultaneously. These findings are in concert
with docking and MD simulations (Figure 5), which suggest
that amiloride and HMA bind in the allosteric sodium pocket,
with the charged guanidinium group anchored by the carboxyl
of Asp2.50. Although the proposed amiloride binding does not
directly overlap with the orthosteric ligand binding site, our
simulations indicate that amiloride derivatives can impact
orthosteric ligand binding indirectly, primarily via modulation of
Trp2466.48 conformation. This explains a more pronounced
negative allosteric effect of HMA, which has extensive steric
interactions with the Trp2466.48 side chain. Overall, the distinct
allosteric effects of amilorides are probably the result of a deli-
cate balance between an improved stability of the inactive
conformation and an indirect (noncompetitive) interference
with the orthosteric site for antagonists.All rights reserved
Structure
Allosteric Effects of Sodium Ions on A2A ReceptorIn summary, a combination of biochemical and thermal stabil-
ity data with MD simulations, based on both inactive and the
active-like crystal structures of the A2AAR, provided valuable
mechanistic insights into the role of the allosteric sodium ion in
the conformational equilibrium of the receptor. Our findings sug-
gest that the binding of either the sodium ion or amilorides to the
allosteric pocket selectively stabilizes the inactive conformation
of the receptor and that this allosteric effect is responsible for the
observed reduction in orthosteric agonist binding. Comprehen-
sive experimental and theoretical analyses of A2AAR in simulta-
neous complex with both allosteric modulators and orthosteric
ligands also explain, on amolecular basis, the distinct interaction
profiles observed between allosteric amiloride derivatives and
different orthosteric antagonists. These observations pave the
way for a better understanding of GPCR allosteric control, which
may be used in the design of novel allosteric modulators to more
precisely tune receptor function.EXPERIMENTAL PROCEDURES
Computational Simulations
The standard amino acid sequence numbering for the human A2AAR is used in
the text, with the Ballesteros and Weinstein residue numbering for GPCRs
(Ballesteros and Weinstein, 1995) shown in superscript if the residue belongs
to a transmembrane helix. The inactive structure of the A2AAR in complex with
ZM241385 and a sodium ion (PDB code 4EIY; Liu et al., 2012) was refined in
order to model the missing loops and add protons as detailed in Supplemental
Experimental Procedures, prior to MD simulations. When the sodium ion was
not considered, manual replacement with a water molecule, also maintaining
the surrounding water molecules, was followed by energy minimization to fully
optimize the H-bond network in the allosteric site. In the simulations with
amiloride, the initial conformation of the A2AAR-amiloride complex was used
as proposed previously by flexible docking (Liu et al., 2012). The starting coor-
dinates of the antagonist caffeine were obtained by superimposing the A2AAR-
caffeine complex (PDB code 3RFM; Dore´ et al., 2011) with the A2AAR structure
described above using PyMOL (PyMOL Molecular Graphics System version
1.4, Schro¨dinger). The MD simulations of the active-like conformation were
performed starting from the A2AAR in complex with the stabilizing agonist
UK432097 (PDB code 3QAK; Xu et al., 2011). The starting coordinates of the
sodium ion and coordinating water molecules were transposed from the inac-
tive structure by structural superimposition with 4EIY. Finally, the A2AAR in
complex with the agonist NECA was obtained by ‘‘morphing’’ the A2AAR-
ZM241385 structure (PDB code 4EIY) to the active-state A2AAR-UK432097
conformation (PDB code 3QAK) and subsequent reconstruction of the intra-
cellular loop 3 as detailed in Supplemental Experimental Procedures. Note
that the available crystal structure of NECA in complex with thermostabilized
A2AAR (PDB code 2YDV; Lebon et al., 2011) was not suitable for this analysis
because of a highly distorted conformation of the allosteric site, which includes
a deformed helix VII backbone due to a cis proline in the NPxxY motif.
Membrane insertion and all MD simulations were performed with the
GROMACS software (Hess et al., 2008) using our original protocol for the
MD simulations of GPCRs (Rodrı´guez et al., 2011) as adapted in the PyMem-
Dyn program (Gutie´rrez-de-Tera´n et al., 2013). The final systems, consisting of
approximately 50,000 atoms (74% belong to solvent molecules, 15% to
lipids, and 11% to protein and ligand atoms), were energy minimized and
equilibrated for a total of 5 ns, with specific details provided in Supplemental
Experimental Procedures. The production phase of unrestrained MD simula-
tions followed for 100 ns simulation time (shorter production times were
considered in certain cases; see Table 1 and explanation inmain text). MD sim-
ulations were performed under the OPLSAA force field (Kaminski et al., 2001),
with ligand parameters obtained with MacroModel (Schro¨dinger, 2009) and
lipid parameters adapted from Berger (Berger et al., 1997), together with the
use of the half-ε double-pairlist method (Chakrabarti et al., 2010) and the
SPC water model (Berendsen et al., 1981). The periodic boundary conditions
were implemented with hexagonal prism-shaped boxes in the isobaric NPTStructure 21, 2175–21ensemble using a Nose-Hoover thermostat (Nose and Klein, 1983) with a
target temperature of 310 K. Electrostatic interactions beyond a cutoff of
12 A˚ were estimated with the particle mesh Ewald method. All MD analyses
were conducted with several GROMACS and visual MD (Humphrey et al.,
1996) utilities. Molecular superimpositions, trajectory visualizations, and
molecular images were performed with PyMOL.
Cell Growth and Transfection
Human embryonic kidney 293T (HEK293T) cells were grown in culture medium
consisting of Dulbecco’s modified Eagle’s medium supplemented with 10%
newborn calf serum, 50 mg/ml streptomycin, and 50 IU/ml penicillin at 37C
and 7% CO2. Cells were subcultured twice a week at a ratio of 1:15 on
10 cm ø plates. Cells were transfected with the wild-type A2AAR-plasmid
(pcDNA3.1, 1 mg) using the calcium phosphate precipitation method
(Sambrook and Fritsch, 1989).
Membrane Preparation
Cells were detached from plates 48 hr after transfection by scraping them into
5 ml PBS and were collected and centrifuged at 7003 g (3,000 rpm) for 5 min.
Pellets derived from 50 plates (10 cm ø) were pooled and resuspended in 40ml
of ice-cold assay buffer (50 mM Tris-HCl supplemented with 5 mM MgCl2
[pH 7.4]). An UltraThurrax was used to homogenize the cell suspension. Mem-
branes and the cytosolic fraction were separated by centrifugation at
100,000 3 g (31,000 rpm) in a Beckman Optima LE-80K ultracentrifuge at
4C for 20 min. The pellet was resuspended in 20 ml of Tris buffer and the
homogenization and centrifugation step was repeated. Assay buffer (10 ml)
was used to resuspend the pellet and adenosine deaminase was added
(0.8 IU/ml) to break down endogenous adenosine. Membranes were stored
in 250 ml aliquots at80C. Membrane protein concentrations were measured
using the BCA (bicinchoninic acid) method (Smith et al., 1985).
Competition and Saturation Binding Assays Using HEK293T Cell
Membranes
For competition binding experiments with [3H]ZM241385 (46.6 Ci/mmol,
American Radiolabeled Chemicals), between 6 and 8 mg of membranes was
used to ensure that total binding was less than 10% of the total radio-
activity added to prevent radioligand depletion. For [3H]NECA (16.3 Ci/
mmol, PerkinElmer) competition binding experiments, between 18 and 25 mg
of membranes was used. Membrane aliquots were incubated in a total volume
of 100 ml of assay buffer at 25C for 2 hr. Radioligand displacement experi-
ments were performed using five concentrations of competing ligand (NaCl,
amiloride or HMA, all from Sigma Aldrich). [3H]ZM241385 and [3H]NECA
were used at concentrations of4.0 nM and 15–20 nM, respectively. Nonspe-
cific binding was determined in the presence of 100 mM CGS21680 (Ascent
Scientific, for experiments with [3H]ZM241385) or 10 mM ZM241385 (Ascent
Scientific, for experiments with [3H]NECA) and represented less than 15% of
the total binding. For saturation experiments, total binding was determined
at increasing concentrations of [3H]ZM241385 (0.10–45 nM) in the absence
or presence of ZM241385 (10 nM), NaCl (30 or 100 mM), amiloride (30 mM),
or HMA (3 mM). In addition, unlabeled NECA (Ascent Scientific) was spiked
with 25% [3H]NECA, resulting in final concentrations of 8.0 to 400 nM, in
the absence or presence of ZM241385 (10 nM), NaCl (30 or 100mM), amiloride
(30 mM), or HMA (4 mM). Nonspecific binding was determined at three
concentrations of radioligand and analyzed by linear regression. Incubations
were terminated by rapid vacuum filtration to separate the bound and free
radioligand through 96-well GF/B filter plates using a Filtermate-harvester
(PerkinElmer). Filters were subsequently washed three times with ice-cold
assay buffer. The filter-bound radioactivity was determined by scintillation
spectrometry using the PE 1450 Microbeta Wallac Trilux scintillation counter
(PerkinElmer).
Thermostability Assays
The A2AAR-BRIL-DC receptor construct was expressed in Spodoptera
frugiperda (Sf9) insect cells and purified in the apo form as described previ-
ously (Liu et al., 2012), except that KCl was used throughout purification
instead of NaCl. N-[4-(7-diethylamino-4-methyl-3-coumarinyl)phenyl]malei-
mide (CPM) dye (Invitrogen) was dissolved in DMSO (Sigma) at 4 mg/ml and
stored at 80C. Before use, the CPM stock solution was thawed and diluted85, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2183
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Allosteric Effects of Sodium Ions on A2A Receptor1:40 in dye dilution buffer (10 mM HEPES [pH 7.50], 10% glycerol, 0.05%
dodecyl maltoside [DDM]; Anatrace). The thermal denaturation assay was
performed with a total volume of 200 ml per sample in a quartz fluorimeter
cuvette (Starna Cells) and an apparent relative Tm was obtained (Alexandrov
et al., 2008). Receptor (4 mg) was diluted in assay buffer (10 mM HEPES
[pH 7.5], 0.05% DDM, 0.01% cholesterol hemisuccinate; Sigma) with and
without different concentrations and combinations of NaCl, amiloride, and
ZM241385 to a final volume of 200 ml. A total of 5 ml of the diluted dye was
added to the protein-containing assay solution and incubated for 30 min at
4C. The mixed solutions were transferred into cuvettes and fluorescence
data were collected by a Cary Eclipse spectrofluorometer (Varian) with a tem-
perature ramping rate of 2C/min. The excitation wavelength was 387 nm and
the emission wavelength was 463 nm. All assays were performed over a tem-
perature range starting from 20C and ramping to 90C.
Data Analysis
The radioligand binding and thermostability data were processed with Prism 5
(GraphPad). Statistical significance was assessed with a Student’s t test.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.str.2013.09.020.
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